Works by Figg, William D.

Results: 240

Cabazitaxel.

Published in:

Cancer Biology & Therapy, 2010, v. 10, n. 12, p. 1233, doi. 10.4161/cbt.10.12.14085

By:

Figg II, William D.;
Figg Sr., William D.

Publication type:

Article

Polypharmacy in View of Advances in Cancer Treatment.

Published in:

Oncology (08909091), 2008, v. 22, n. 9, p. 1055

By:

Jain, Lokesh;
Figg, William D.

Publication type:

Article

Sifting Through the Multitude of Novel Therapies for Prostate Cancer.

Published in:

Oncology (08909091), 2006, v. 20, n. 14, p. 1792

By:

Ahlers, Christoph M.;
Figg, William D.

Publication type:

Article

Hormone-Refractory Prostate Cancer: Where are We Going?

Published in:

Drugs, 2007, v. 67, n. 8, p. 1109, doi. 10.2165/00003495-200767080-00002

By:

Di Lorenzo, Giuseppe;
Autorino, Riccardo;
Figg, William D.;
De Placido, Sabino

Publication type:

Article

The effect of an adenosine A2A agonist on intra-tumoral concentrations of temozolomide in patients with recurrent glioblastoma.

Published in:

Fluids & Barriers of the CNS, 2018, v. 15, p. 1, doi. 10.1186/s12987-017-0088-8

By:

Jackson, Sadhana;
Weingart, Jon;
Nduom, Edjah K.;
Harfi, Thura T.;
George, Richard T.;
McAreavey, Dorothea;
Ye, Xiaobu;
Anders, Nicole M.;
Peer, Cody;
Figg, William D.;
Gilbert, Mark;
Rudek, Michelle A.;
Grossman, Stuart A.

Publication type:

Article

Dual mTORC1/2 inhibition compromises cell defenses against exogenous stress potentiating Obatoclax-induced cytotoxicity in atypical teratoid/rhabdoid tumors.

Published in:

Cell Death & Disease, 2022, v. 13, n. 4, p. 1, doi. 10.1038/s41419-022-04868-9

By:

Parkhurst, Ashlyn;
Wang, Sabrina Z.;
Findlay, Tyler R.;
Malebranche, Kristen J.;
Odabas, Arman;
Alt, Jesse;
Maxwell, Micah J.;
Kaur, Harpreet;
Peer, Cody J.;
Figg, William D.;
Warren, Katherine E.;
Slusher, Barbara S.;
Eberhart, Charles G.;
Raabe, Eric H.;
Rubens, Jeffrey A.

Publication type:

Article

Targeting Pancreatic Cancer Cells and Stellate Cells Using Designer Nanotherapeutics in vitro.

Published in:

International Journal of Nanomedicine, 2020, v. 15, p. 991, doi. 10.2147/IJN.S234112

By:

Elechalawar, Chandra Kumar;
Hossen, Md Nazir;
Shankarappa, Priya;
Peer, Cody J;
Figg, William D;
Robertson, J David;
Bhattacharya, Resham;
Mukherjee, Priyabrata

Publication type:

Article

Reproducibility of pharmacogenetics findings for paclitaxel in a heterogeneous population of patients with lung cancer.

Published in:

PLoS ONE, 2019, v. 14, n. 2, p. 1, doi. 10.1371/journal.pone.0212097

By:

Sissung, Tristan M.;
Rajan, Arun;
Blumenthal, Gideon M.;
Liewehr, David J.;
Steinberg, Seth M.;
Berman, Arlene;
Giaccone, Giuseppe;
Figg, William D.

Publication type:

Article

Reversal of Docetaxel Resistance With Bevacizumab and Thalidomide.

Published in:

Clinical Genitourinary Cancer, 2009, v. 7, n. 2, p. E37, doi. 10.3816/CGC.2009.n.020

By:

Ning, Yang-min;
Figg, William D.;
Dahut, William L.

Publication type:

Article

In Silico Re‐Optimization of Atezolizumab Dosing Using Population Pharmacokinetic Simulation and Exposure–Response Simulation.

Published in:

Journal of Clinical Pharmacology, 2023, v. 63, n. 6, p. 672, doi. 10.1002/jcph.2203

By:

Peer, Cody J.;
Schmidt, Keith T.;
Arisa, Oluwatobi;
Richardson, William J.;
Paydary, Koosha;
Goldstein, Daniel A.;
Gulley, James L.;
Figg, William D.;
Ratain, Mark J.

Publication type:

Article

Pharmacokinetic Simulation Analysis of Less Frequent Nivolumab and Pembrolizumab Dosing: Pharmacoeconomic Rationale for Dose Deescalation.

Published in:

Journal of Clinical Pharmacology, 2022, v. 62, n. 4, p. 532, doi. 10.1002/jcph.1984

By:

Peer, Cody J.;
Heiss, Brian L.;
Goldstein, Daniel A.;
Goodell, Jennifer C.;
Figg, William D.;
Ratain, Mark J.

Publication type:

Article

TMPRSS2: Potential Biomarker for COVID‐19 Outcomes.

Published in:

Journal of Clinical Pharmacology, 2020, v. 60, n. 7, p. 801, doi. 10.1002/jcph.1641

By:

Strope, Jonathan D.;
PharmD, Cindy H. Chau;
Figg, William D.

Publication type:

Article

Drug-drug Interactions in Patients with HIV and Cancer in Sub-Saharan Africa.

Published in:

AIDS Reviews, 2021, v. 23, n. 1, p. 13, doi. 10.24875/AIDSRev.20000005

By:

Strope, Jonathan D.;
Lochrin, Sarah E.;
Sissung, Tristan M.;
Kem, Ravie;
Chandrasekaran, Prabha;
Sharon, Elad;
Price, Douglas K.;
Uldrick, Thomas S.;
Yarchoan, Robert;
Figg, William D.

Publication type:

Article

Determination of paclitaxel in human plasma following the administration of Genaxol or Genetaxyl by liquid chromatography/tandem mass spectrometry.

Published in:

Rapid Communications in Mass Spectrometry: RCM, 2006, v. 20, n. 14, p. 2170, doi. 10.1002/rcm.2577

By:

Gardner, Erin R.;
Liau, Chi-Ting;
Chu, Zyting E.;
Figg, William D.;
Sparreboom, Alex

Publication type:

Article

Determination of 2-methoxyestradiol in human plasma, using liquid chromatography/tandem mass spectrometry.

Published in:

Rapid Communications in Mass Spectrometry: RCM, 2005, v. 19, n. 9, p. 1176, doi. 10.1002/rcm.1902

By:

Lakhani, Nehal J.;
Lepper, Erin R.;
Sparreboom, Alex;
Dahut, William L.;
Venitz, Jürgen;
Figg, William D.

Publication type:

Article

Cytochrome 450 1B1 (CYP1B1) polymorphisms associated with response to docetaxel in Castration-Resistant Prostate Cancer (CRPC)patients.

Published in:

BMC Cancer, 2010, v. 10, p. 511, doi. 10.1186/1471-2407-10-511

By:

Pastina, Ilaria;
Giovannetti, Elisa;
Chioni, Aldo;
Sissung, Tristan M.;
Crea, Francesco;
Orlandini, Cinzia;
Price, Douglas K.;
Cianci, Claudia;
Figg, William D.;
Ricci, Sergio;
Danesi, Romano

Publication type:

Article

Alemtuzumab clearance, lymphocyte count, and T‐cell chimerism after hematopoietic stem cell transplant in sickle cell disease.

Published in:

Pharmacotherapy, 2022, v. 42, n. 1, p. 14, doi. 10.1002/phar.2641

By:

Furstenau, Dana;
Peer, Cody J.;
Hughes, Thomas E.;
Uchida, Naoya;
Tisdale, John;
Hall, Oliver Morgan;
Figg, William D.;
Hsieh, Matthew

Publication type:

Article

COVID‐19 Clinical Diagnostics and Testing Technology.

Published in:

Pharmacotherapy, 2020, v. 40, n. 8, p. 857, doi. 10.1002/phar.2439

By:

Chau, Cindy H.;
Strope, Jonathan D.;
Figg, William D.

Publication type:

Article

The effect of anti-CTLA4 treatment on peripheral and intra-tumoral T cells in patients with hepatocellular carcinoma.

Published in:

Cancer Immunology, Immunotherapy, 2019, v. 68, n. 4, p. 599, doi. 10.1007/s00262-019-02299-8

By:

Agdashian, David;
ElGindi, Mei;
Xie, Changqing;
Sandhu, Milan;
Pratt, Drew;
Kleiner, David E.;
Figg, William D.;
Rytlewski, Julie A.;
Sanders, Catherine;
Yusko, Erik C.;
Wood, Bradford;
Venzon, David;
Brar, Gagandeep;
Duffy, Austin G.;
Greten, Tim F.;
Korangy, Firouzeh

Publication type:

Article

Treatment with novel topoisomerase inhibitors in Ewing sarcoma models reveals heterogeneity of tumor response.

Published in:

Frontiers in Cell & Developmental Biology, 2024, p. 1, doi. 10.3389/fcell.2024.1462840

By:

Lee, Unsun;
Szabova, Ludmila;
Collins, Victor J.;
Gordon, Melanie;
Johnson, Kristine;
Householder, Deborah;
Jorgensen, Stephanie;
Lu, Lucy;
Bassel, Laura;
Elloumi, Fathi;
Peer, Cody J.;
Nelson, Ariana E.;
Varriano, Sophia;
Varma, Sudhir;
Roberts, Ryan D.;
Ohler, Zoe Weaver;
Figg, William D.;
Sharan, Shyam K.;
Pommier, Yves;
Heske, Christine M.

Publication type:

Article

An Optimized Method for the quantitation of Carboxyamidotriazole (CAI) in Human Plasma with Solid Phase Extraction and reversed Phase HPLC.

Published in:

Analytical Letters, 1997, v. 30, n. 11, p. 2009, doi. 10.1080/00032719708001717

By:

Simmons, Bradley R.;
Bauer, Kenneth S.;
McCall, Natalie A.;
Kohn, Elise C.;
Figg, William D.

Publication type:

Article

The Role of MRI in Prostate Cancer Active Surveillance.

Published in:

BioMed Research International, 2014, v. 2014, p. 1, doi. 10.1155/2014/203906

By:

Johnson, Linda M.;
Choyke, Peter L.;
Figg, William D.;
Turkbey, Baris

Publication type:

Article

Subcutaneous Atezolizumab: A Jab Without a Benefit.

Published in:

Clinical Pharmacology in Drug Development, 2022, v. 11, n. 1, p. 134, doi. 10.1002/cpdd.1061

By:

Peer, Cody J.;
Zimmerman, Sara M.;
Figg, William D.;
Goldstein, Daniel A.;
Ratain, Mark J.

Publication type:

Article

Associations between polymorphisms in genes related to estrogen metabolism and function and prostate cancer risk: results from the Prostate Cancer Prevention Trial.

Published in:

Carcinogenesis, 2018, v. 39, n. 2, p. 125, doi. 10.1093/carcin/bgx144

By:

Li Tang;
Platek, Mary E.;
Song Yao;
Till, Cathee;
Goodman, Phyllis J.;
Tangen, Catherine M.;
Yue Wu;
Platz, Elizabeth A.;
Neuhouser, Marian L.;
Stanczyk, Frank Z.;
Reichardt, Juergen K. V.;
Santella, Regina M.;
Hsing, Ann;
Figg, William D.;
Lippman, Scott M.;
Thompson, Ian M.;
Ambrosone, Christine B.

Publication type:

Article

A Phase I/II Study of High-Dose Tamoxifen in Combination with Vinblastine in Patients with Androgen-Independent Prostate Cancer.

Published in:

Acta Oncologica, 2003, v. 42, n. 3, p. 195, doi. 10.1080/02841860310010718

By:

Hamilton, Michael;
Dahut, William;
Brawley, Otis;
Davis, Patricia;
Wells-jones, Toni;
Kohler, David;
Duray, Paul;
Liewehr, David J.;
Lakhani, Nehal;
Steinberg, Seth M.;
Figg, William D.;
Reed, Eddie

Publication type:

Article

Finasteride Concentrations and Prostate Cancer Risk: Results from the Prostate Cancer Prevention Trial.

Published in:

PLoS ONE, 2015, v. 10, n. 5, p. 1, doi. 10.1371/journal.pone.0126672

By:

Chau, Cindy H.;
Price, Douglas K.;
Till, Cathee;
Goodman, Phyllis J.;
Chen, Xiaohong;
Leach, Robin J.;
Johnson-Pais, Teresa L.;
Hsing, Ann W.;
Hoque, Ashraful;
Tangen, Catherine M.;
Chu, Lisa;
Parnes, Howard L.;
Schenk, Jeannette M.;
Reichardt, Juergen K. V.;
Thompson, Ian M.;
Figg, William D.

Publication type:

Article

Important Role of CYP2J2 in Protein Kinase Inhibitor Degradation: A Possible Role in Intratumor Drug Disposition and Resistance.

Published in:

PLoS ONE, 2014, v. 9, n. 5, p. 1, doi. 10.1371/journal.pone.0095532

By:

Narjoz, Céline;
Favre, Amélie;
McMullen, Justin;
Kiehl, Philippe;
Montemurro, Michael;
Figg, William D.;
Beaune, Philippe;
de Waziers, Isabelle;
Rochat, Bertrand

Publication type:

Article

Expression of OATP Family Members in Hormone-Related Cancers: Potential Markers of Progression.

Published in:

PLoS ONE, 2011, v. 6, n. 5, p. 1, doi. 10.1371/journal.pone.0020372

By:

Pressler, Heather;
Sissung, Tristan M.;
Venzon, David;
Price, Douglas K.;
Figg, William D.

Publication type:

Article

Safety and Feasibility of Long-term Intravenous Sodium Nitrite Infusion in Healthy Volunteers.

Published in:

PLoS ONE, 2011, v. 6, n. 1, p. 1, doi. 10.1371/journal.pone.0014504

By:

Pluta, Ryszard M.;
Oldfield, Edward H.;
Bakhtian, Kamran D.;
Fathi, Ali Reza;
Smith, René K.;
DeVroom, Hetty L.;
Nahavandi, Masoud;
Sukyung Woo;
Figg, William D.;
Lonser, Russell R.

Publication type:

Article

Association of androgen metabolism gene polymorphisms with prostate cancer risk and androgen concentrations: Results from the Prostate Cancer Prevention Trial.

Published in:

2016

By:

Price, Douglas K.;
Chau, Cindy H.;
Till, Cathee;
Goodman, Phyllis J.;
Leach, Robin J.;
Johnson‐Pais, Teresa L.;
Hsing, Ann W.;
Hoque, Ashraful;
Parnes, Howard L.;
Schenk, Jeannette M.;
Tangen, Catherine M.;
Thompson, Ian M.;
Reichardt, Juergen K. V.;
Figg, William D.

Publication type:

journal article

Cardiac toxicity in a pilot study of duvelisib and ibrutinib combination therapy for chronic lymphocytic leukaemia.

Published in:

British Journal of Haematology, 2023, v. 200, n. 2, p. 261, doi. 10.1111/bjh.18558

By:

Paul, Shira R.;
Rosing, Douglas R.;
Haigney, Mark C.;
Peer, Cody J.;
Figg, William D.;
Wiestner, Adrian;
Sun, Clare

Publication type:

Article

Evaluation of entinostat alone and in combination with standard-of-care cytotoxic agents against rhabdomyosarcoma xenograft models.

Published in:

2019

By:

Kurmasheva, Raushan T.;
Bandyopadhyay, Abhik;
Favours, Edward;
Del Pozo, Vanessa;
Ghilu, Samson;
Phelps, Doris A.;
Erickson, Stephen W.;
Peer, Cody J.;
Figg, William D.;
Smith, Malcolm A.;
Houghton, Peter J.

Publication type:

journal article

Phase 1 trial and pharmacokinetic study of the oral platinum analog satraplatin in children and young adults with refractory solid tumors including brain tumors.

Published in:

Pediatric Blood & Cancer, 2015, v. 62, n. 4, p. 603, doi. 10.1002/pbc.25344

By:

Akshintala, Srivandana;
Marcus, Leigh;
Warren, Katherine E.;
Murphy, Robert F.;
Sissung, Tristan M.;
Srivastava, Anjali;
Goodspeed, Wendy J.;
Goodwin, Anne;
Brewer, Carmen C.;
Zalewski, Christopher;
King, Kelly A.;
Kim, AeRang;
Figg, William D.;
Widemann, Brigitte C.

Publication type:

Article

Role of cereblon in angiogenesis and in mediating the antiangiogenic activity of immunomodulatory drugs.

Published in:

FASEB Journal, 2020, v. 34, n. 9, p. 11395, doi. 10.1096/fj.201903060RR

By:

Beedie, Shaunna L.;
Huang, Phoebe A.;
Harris, Emily M.;
Strope, Jonathan D.;
Mahony, Christopher;
Chau, Cindy H.;
Vargesson, Neil;
Figg, William D.

Publication type:

Article

The differentiating agent phenylacetate increases prostate-specific antigen production by prostate cancer cells.

Published in:

Prostate, 1996, v. 29, n. 3, p. 177, doi. 10.1002/(SICI)1097-0045(199609)29:3<177::AID-PROS3>3.0.CO;2-B

By:

Walls, Ronald;
Thibault, Alain;
Liu, Lei;
Wood, Chris;
Kozlowsky, James;
Figg, William D.;
Sampson, Maureen L.;
Elin, Ronald J.;
Samid, Dvorit

Publication type:

Article

Recent advances in pharmacogenetic approaches to anticancer drug development.

Published in:

Drug Development Research, 2004, v. 62, n. 3, p. 233, doi. 10.1002/ddr.10361

By:

Nicola F. Smith;
William D. Figg;
Alex Sparreboom

Publication type:

Article

Gleason score and pretreatment prostate-specific antigen in survival among patients with stage D2 prostate cancer.

Published in:

World Journal of Urology, 2004, v. 22, n. 6, p. 425, doi. 10.1007/s00345-004-0443-7

By:

Figg, William D.;
Franks, Michael E.;
Venzon, David;
Duray, Paul;
Cox, Michael C.;
Linehan, W. Marston;
Van Bingham, W.;
Eastham, James A.;
Reed, Eddie;
Sartor, Oliver

Publication type:

Article

Luteal phase dose-response relationships of the antiprogestin CDB-2914 in normally cycling women.

Published in:

2003

By:

Passaro, Maureen D;
Piquion, Johann;
Mullen, Nancy;
Sutherland, Dorette;
Zhai, Suoping;
Figg, William D;
Blye, Richard;
Nieman, Lynnette K

Publication type:

journal article

Requests to Be a Content Expert Reviewer for Journals I Am Not Affiliated With: A Major, Ongoing Problem for the Academic Community.

Published in:

Journal of Pediatric Pharmacology & Therapeutics, 2024, v. 29, n. 6, p. 674, doi. 10.5863/1551-6776-29.6.674

By:

Figg Sr, William D.

Publication type:

Article

Phase I/Ib study of olaparib and carboplatin in BRCA1 or BRCA2 mutation-associated breast or ovarian cancer with biomarker analyses.

Published in:

2014

By:

Lee, Jung-Min;
Hays, John L;
Annunziata, Christina M;
Noonan, Anne M;
Minasian, Lori;
Zujewski, Jo Anne;
Yu, Minshu;
Gordon, Nicolas;
Ji, Jiuping;
Sissung, Tristan M;
Figg, William D;
Azad, Nilofer;
Wood, Bradford J;
Doroshow, James;
Kohn, Elise C

Publication type:

journal article

Phase l/lb Study of Olaparib and Carboplatin in BRCA1 or BRCA2 Mutation-Associated Breast or Ovarian Cancer With Biomarker Analyses.

Published in:

JNCI: Journal of the National Cancer Institute, 2014, v. 106, n. 6, p. 1, doi. 10.1093/jnci/dju089

By:

Jung-Min Lee;
Hays, John L.;
Annunziata, Christina M.;
Noonan, Anne M.;
Minasian, Lori;
Zujewski, Jo Anne;
Minshu Yu;
Gordon, Nicolas;
Jiuping Ji;
Sissung, Tristan M.;
Figg, William D.;
Azad, Nilofer;
Wood, Bradford J.;
Doroshow, James;
Kohn, Elise C.

Publication type:

Article

Cancer Pharmacogenomics and Pharmacoepidemiology: Setting a Research Agenda to Accelerate Translation.

Published in:

JNCI: Journal of the National Cancer Institute, 2010, v. 102, n. 22, p. 1698, doi. 10.1093/jnci/djq390

By:

Freedman, Andrew N.;
Sansbury, Leah B.;
Figg, William D.;
Potosky, Arnold L.;
Smith, Sheila R. Weiss;
Khoury, Muin J.;
Nelson, Stefanie A.;
Weinshilboum, Richard M.;
Ratain, Mark J.;
McLeod, Howard L.;
Epstein, Robert S.;
Ginsburg, Geoffrey S.;
Schilsky, Richard L.;
Liu, Geoffrey;
Flockhart, David A.;
Ulrich, Cornelia M.;
Davis, Robert L.;
Lesko, Lawrence J.;
Zineh, Issam;
Randhawa, Gurvaneet

Publication type:

Article

Bridging Health Disparities: a Genomics and Transcriptomics Analysis by Race in Prostate Cancer.

Published in:

Journal of Racial & Ethnic Health Disparities, 2024, v. 11, n. 1, p. 492, doi. 10.1007/s40615-023-01534-4

By:

Lee, Kristi Y.;
Beatson, Erica L.;
Steinberg, Seth M.;
Chau, Cindy H.;
Price, Douglas K.;
Figg, William D.

Publication type:

Article

Integrating pharmacogenetic information and clinical decision support into the electronic health record.

Published in:

Journal of the American Medical Informatics Association, 2014, v. 21, n. 3, p. 522, doi. 10.1136/amiajnl-2013-001873

By:

Goldspiel, Barry R.;
Flegel, Willy A.;
Di Patrizio, Gary;
Sissung, Tristan;
Adams, Sharon D.;
Penzak, Scott R.;
Biesecker, Leslie G.;
Fleisher, Thomas A.;
Patel, Jharana J.;
Herion, David;
Figg, William D.;
Lertora, Juan J. L.;
McKeeby, Jon W.

Publication type:

Article

Androgen receptor splice variant 7 (AR‐V7) and AR full‐length (AR‐FL) as predictive biomarkers of therapeutic resistance: partners in crime?

Published in:

BJU International, 2019, v. 124, n. 4, p. 549, doi. 10.1111/bju.14869

By:

Barbier, Roberto H.;
Chau, Cindy H.;
Figg, William D.

Publication type:

Article

A phase I study of TRC105 anti-endoglin ( CD105) antibody in metastatic castration-resistant prostate cancer.

Published in:

BJU International, 2015, v. 116, n. 4, p. 546, doi. 10.1111/bju.12986

By:

Karzai, Fatima H.;
Apolo, Andrea B.;
Cao, Liang;
Madan, Ravi A.;
Adelberg, David E.;
Parnes, Howard;
McLeod, David G.;
Harold, Nancy;
Peer, Cody;
Yu, Yunkai;
Tomita, Yusuke;
Lee, Min‐Jung;
Lee, Sunmin;
Trepel, Jane B.;
Gulley, James L.;
Figg, William D.;
Dahut, William L.

Publication type:

Article

Phase II clinical trial of cediranib in patients with metastatic castration-resistant prostate cancer.

Published in:

BJU International, 2013, v. 111, n. 8, p. 1269, doi. 10.1111/j.1464-410X.2012.11667.x

By:

Dahut, William L.;
Madan, Ravi A.;
Karakunnel, Joyson J.;
Adelberg, David;
Gulley, James L.;
Turkbey, Ismail B.;
Chau, Cindy H.;
Spencer, Shawn D.;
Mulquin, Marcia;
Wright, John;
Parnes, Howard L.;
Steinberg, Seth M.;
Choyke, Peter L.;
Figg, William D.

Publication type:

Article

Tofacitinib to prevent anti-drug antibody formation against LMB-100 immunotoxin in patients with advanced mesothelin-expressing cancers.

Published in:

Frontiers in Oncology, 2024, p. 01, doi. 10.3389/fonc.2024.1386190

By:

Skorupan, Nebojsa;
Peer, Cody J.;
Xianyu Zhang;
Hyoyoung Choo-Wosoba;
Ahmad, Mehwish I.;
Min-Jung Lee;
Shraddha Rastogi;
Nahoko Sato;
Yunkai Yu;
Pegna, Guillaume Joe;
Steinberg, Seth M.;
Kalsi, Shelley S.;
Liang Cao;
Figg, William D.;
Trepel, Jane B.;
Pastan, Ira;
FitzGerald, David;
Alewine, Christine

Publication type:

Article

Inhibition of p38α MAPK restores neuronal p38γ MAPK and ameliorates synaptic degeneration in a mouse model of DLB/PD.

Published in:

Science Translational Medicine, 2023, v. 15, n. 695, p. 1, doi. 10.1126/scitranslmed.abq6089

By:

Iba, Michiyo;
Kim, Changyoun;
Kwon, Somin;
Szabo, Marcell;
Horan-Portelance, Liam;
Peer, Cody J.;
Figg, William D.;
Reed, Xylena;
Ding, Jinhui;
Lee, Seung-Jae;
Rissman, Robert A.;
Cookson, Mark R.;
Overk, Cassia;
Wrasidlo, Wolf;
Masliah, Eliezer

Publication type:

Article

Alterations of human skin microbiome and expansion of antimicrobial resistance after systemic antibiotics.

Published in:

Science Translational Medicine, 2021, v. 13, n. 625, p. 1, doi. 10.1126/scitranslmed.abd8077

By:

Jo, Jay-Hyun;
Harkins, Catriona P.;
Schwardt, Nicole H.;
Portillo, Jessica A.;
Zimmerman, Matthew D.;
Carter, Claire L.;
Hossen, Md Amir;
Peer, Cody J.;
Polley, Eric C.;
Dartois, Véronique;
Figg, William D.;
Moutsopoulos, Niki M.;
Segre, Julia A.;
Kong, Heidi H.

Publication type:

Article